
Repligen Corporation RGEN
$ 105.54
2.09%
Quarterly report 2026-Q1
added 05-06-2026
Repligen Corporation EV - Enterprise Value 2011-2026 | RGEN
Annual EV - Enterprise Value Repligen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 284 M | 108 M | 126 M | 107 M | 19 M | -333 M | 4.73 B | 2.41 B | 1.35 B | 968 M | 698 M | 771 M | 476 M | 197 M | 117 M | 92.7 M | -5.04 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.73 B | -333 M | 712 M |
EV - Enterprise Value of other stocks in the Medical instruments industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
20.4 B | $ 60.79 | 0.68 % | $ 12.1 B | ||
|
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
5.71 B | $ 115.17 | 0.88 % | $ 3.69 B | ||
|
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | ||
|
ICU Medical
ICUI
|
3.36 B | $ 121.75 | -1.01 % | $ 3 B | ||
|
Repro Med Systems
KRMD
|
201 M | $ 3.89 | -2.26 % | $ 180 M | ||
|
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
170 B | $ 426.62 | -0.34 % | $ 152 B | ||
|
LeMaitre Vascular
LMAT
|
2.73 B | $ 99.14 | -0.36 % | $ 2.24 B | ||
|
Alcon
ALC
|
7.99 B | $ 64.53 | 0.8 % | $ 40.4 B | ||
|
Masimo Corporation
MASI
|
10.4 B | $ 178.4 | 0.03 % | $ 9.51 B | ||
|
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
36 M | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
3.62 B | $ 23.88 | 0.13 % | $ 4.01 B | ||
|
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
13.4 M | $ 6.3 | -2.02 % | $ 53.4 K | ||
|
Haemonetics Corporation
HAE
|
2.76 B | $ 56.86 | -0.4 % | $ 2.86 B | ||
|
STAAR Surgical Company
STAA
|
895 M | $ 31.88 | -0.42 % | $ 1.58 B | ||
|
STERIS plc
STE
|
27.5 B | $ 215.75 | -0.17 % | $ 21.3 B | ||
|
Teleflex Incorporated
TFX
|
8.89 B | $ 130.11 | -0.13 % | $ 5.81 B | ||
|
Isoray
ISR
|
29.3 M | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
4.69 B | $ 142.59 | 0.3 % | $ 6.91 B | ||
|
InfuSystem Holdings
INFU
|
157 M | $ 8.53 | -1.24 % | $ 176 M | ||
|
Microbot Medical
MBOT
|
120 M | $ 1.92 | 3.51 % | $ 87.9 M | ||
|
Milestone Scientific
MLSS
|
27.7 M | $ 0.34 | -0.15 % | $ 27.9 M | ||
|
Merit Medical Systems
MMSI
|
5.51 B | $ 62.51 | -0.08 % | $ 3.7 B | ||
|
Utah Medical Products
UTMD
|
117 M | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
17.9 B | $ 302.94 | 0.92 % | $ 21.9 B | ||
|
Pulse Biosciences
PLSE
|
1.64 B | $ 24.97 | -7.88 % | $ 1.68 B | ||
|
DENTSPLY SIRONA
XRAY
|
6.29 B | $ 10.04 | -3.6 % | $ 2 B | ||
|
Retractable Technologies
RVP
|
85.7 M | $ 0.69 | - | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
175 M | $ 59.29 | 1.09 % | $ 195 M | ||
|
Predictive Oncology
POAI
|
-5.62 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
989 M | $ 20.77 | -1.36 % | $ 992 M | ||
|
Stereotaxis
STXS
|
191 M | $ 1.88 | -3.34 % | $ 171 M | ||
|
Baxter International
BAX
|
21.6 B | $ 17.56 | -1.29 % | $ 9.01 B | ||
|
ResMed
RMD
|
36.5 B | $ 204.64 | 1.03 % | $ 29.9 B | ||
|
AtriCure
ATRC
|
1.55 B | $ 28.64 | 1.72 % | $ 1.37 B | ||
|
Harvard Bioscience
HBIO
|
78.6 M | $ 5.48 | -0.69 % | $ 243 M | ||
|
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
396 M | $ 11.01 | -0.18 % | $ 450 M | ||
|
Becton, Dickinson and Company
BDX
|
55.5 B | $ 143.69 | -0.57 % | $ 41.3 B | ||
|
Nephros
NEPH
|
31.3 M | $ 3.21 | -3.94 % | $ 34.1 M | ||
|
OraSure Technologies
OSUR
|
98.2 M | $ 3.04 | 3.05 % | $ 223 M |